Loftus, Edward V

Danese, Silvio; Vermeire, Séverine; Zhou, Wen; Pangan, Aileen L; Siffledeen, Jesse; Greenbloom, Susan; Hébuterne, Xavier; D'Haens, Geert; Nakase, Hiroshi; Panés, Julian; Higgins, Peter D R; Juillerat, Pascal; Lindsay, James O; Loftus, Edward V; Sandborn, William J; Reinisch, Walter; Chen, Min-Hu; Sanchez Gonzalez, Yuri; Huang, Bidan; Xie, Wangang; ... (2022). Upadacitinib as induction and maintenance therapy for moderately to severely active ulcerative colitis: results from three phase 3, multicentre, double-blind, randomised trials. The lancet, 399(10341), pp. 2113-2128. Elsevier 10.1016/S0140-6736(22)00581-5

Peyrin-Biroulet, Laurent; Hart, Ailsa; Bossuyt, Peter; Long, Millie; Allez, Matthieu; Juillerat, Pascal; Armuzzi, Alessandro; Loftus, Edward V; Ostad-Saffari, Elham; Scalori, Astrid; Oh, Young S; Tole, Swati; Chai, Akiko; Pulley, Jennifer; Lacey, Stuart; Sandborn, William J (2022). Etrolizumab as induction and maintenance therapy for ulcerative colitis in patients previously treated with tumour necrosis factor inhibitors (HICKORY): a phase 3, randomised, controlled trial. The lancet. Gastroenterology & hepatology, 7(2), pp. 128-140. Elsevier 10.1016/S2468-1253(21)00298-3